Literature DB >> 10617608

Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I.

M Y El-Mir1, V Nogueira, E Fontaine, N Avéret, M Rigoulet, X Leverve.   

Abstract

We report here a new mitochondrial regulation occurring only in intact cells. We have investigated the effects of dimethylbiguanide on isolated rat hepatocytes, permeabilized hepatocytes, and isolated liver mitochondria. Addition of dimethylbiguanide decreased oxygen consumption and mitochondrial membrane potential only in intact cells but not in permeabilized hepatocytes or isolated mitochondria. Permeabilized hepatocytes after dimethylbiguanide exposure and mitochondria isolated from dimethylbiguanide pretreated livers or animals were characterized by a significant inhibition of oxygen consumption with complex I substrates (glutamate and malate) but not with complex II (succinate) or complex IV (N,N,N',N'-tetramethyl-1, 4-phenylenediamine dihydrochloride (TMPD)/ascorbate) substrates. Studies using functionally isolated complex I obtained from mitochondria isolated from dimethylbiguanide-pretreated livers or rats further confirmed that dimethylbiguanide action was located on the respiratory chain complex I. The dimethylbiguanide effect was temperature-dependent, oxygen consumption decreasing by 50, 20, and 0% at 37, 25, and 15 degrees C, respectively. This effect was not affected by insulin-signaling pathway inhibitors, nitric oxide precursor or inhibitors, oxygen radical scavengers, ceramide synthesis inhibitors, or chelation of intra- or extracellular Ca(2+). Because it is established that dimethylbiguanide is not metabolized, these results suggest the existence of a new cell-signaling pathway targeted to the respiratory chain complex I with a persistent effect after cessation of the signaling process.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10617608     DOI: 10.1074/jbc.275.1.223

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  537 in total

Review 1.  The blooming of the French lilac.

Authors:  L A Witters
Journal:  J Clin Invest       Date:  2001-10       Impact factor: 14.808

2.  The combination of metformin and 2-deoxyglucose significantly inhibits cyst formation in miniature pigs with polycystic kidney disease.

Authors:  Xiaoying Lian; Xiaoyuan Wu; Zhongxin Li; Yingjie Zhang; Kangkang Song; Guangyan Cai; Qinggang Li; Shupeng Lin; Xiangmei Chen; Xue-Yuan Bai
Journal:  Br J Pharmacol       Date:  2019-01-10       Impact factor: 8.739

3.  Metformin therapy for the reproductive and metabolic consequences of polycystic ovary syndrome.

Authors:  Susan Sam; David A Ehrmann
Journal:  Diabetologia       Date:  2017-08-03       Impact factor: 10.122

4.  Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain.

Authors:  M R Owen; E Doran; A P Halestrap
Journal:  Biochem J       Date:  2000-06-15       Impact factor: 3.857

Review 5.  Cardiovascular impact of drugs used in the treatment of diabetes.

Authors:  Chris R Triggle; Hong Ding
Journal:  Ther Adv Chronic Dis       Date:  2014-11       Impact factor: 5.091

Review 6.  AMP-activated protein kinase: an energy sensor that regulates all aspects of cell function.

Authors:  D Grahame Hardie
Journal:  Genes Dev       Date:  2011-09-15       Impact factor: 11.361

7.  AMP-activated protein kinase (AMPK) activating agents cause dephosphorylation of Akt and glycogen synthase kinase-3.

Authors:  Taj D King; Ling Song; Richard S Jope
Journal:  Biochem Pharmacol       Date:  2006-03-10       Impact factor: 5.858

8.  Changing the energy of an immune response.

Authors:  Meghan M Delmastro-Greenwood; Jon D Piganelli
Journal:  Am J Clin Exp Immunol       Date:  2013-02-27

Review 9.  Metabolism of inflammation limited by AMPK and pseudo-starvation.

Authors:  Luke A J O'Neill; D Grahame Hardie
Journal:  Nature       Date:  2013-01-17       Impact factor: 49.962

10.  Functional organic cation transporters mediate osteogenic response to metformin in human umbilical cord mesenchymal stromal cells.

Authors:  Faisal E Al Jofi; Tao Ma; Dong Guo; Monica P Schneider; Yan Shu; Hockin H K Xu; Abraham Schneider
Journal:  Cytotherapy       Date:  2018-03-16       Impact factor: 5.414

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.